Alternating intravenous racemic ketamine and electroconvulsive therapy in treatment resistant depression: A case report
European Psychiatry April 1, 2017 Lucie Bartova, A. Weidenauer, M. Dold et al.
IntroductionTreatment resistant depression (TRD) affecting approximately 10–30% of all depressed patients often remains misdiagnosed and undertreated, leading to a higher risk of relapse and suicide. Electroconvulsive therapy (ECT) and sub-anesthetic ketamine have repeatedly shown to be effective in the TRD population. Administering ketamine as an anesthetic component to augment antidepressant...